Logo Image
|Articles|October 2, 2013

Viroclinics Biosciences expands with Clinical Trial Operations Services

To provide better support for the pharmaceutical, biotechnology, and medical device industries, Viroclinics has started a specialized group for clinical trial operations.

To provide better support for the pharmaceutical, biotechnology, and medical device industries, Viroclinics has started a specialized group for clinical trial operations. Activities involve preparation of virology sampling kits, on-site sampling handling instruction, courier transport, sample tracking and tracing, and management of sample processing labs. For a smooth logistical flow of samples from all over the globe, Viroclinics works together with sites in Europe, Russia, Ukraine, Australia, New Zealand, USA, Canada, Mexico, Central America region (e.g., Guatemala, El Salvador), South America (Brazil, Argentina, Colombia, Peru, Chile) and South Africa.

The company is demonstrating its sample kits at the InfectiousDisease Week 2013 conference this week in San Francisco.

Related to this article

View more
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
What "Patient Voice" Actually Requires: Beyond the Buzzword
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
Read more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more